# A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

> **NCT07521241** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Addpharma Inc.** · enrollment: 52 (estimated)

## Conditions studied

- Chronic Liver Disease (CLD)

## Interventions

- **DRUG:** AD-230, AD-2301

## Key facts

- **NCT ID:** NCT07521241
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07521241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07521241, "A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07521241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*